Quipt Home Medical (QIPT) to Release Quarterly Earnings on Monday

Key Points

• Quipt Home Medical (QIPT) is set to release its Q3 2025 earnings on August 11th, with analysts predicting earnings of $0.03 per share and revenue of $80.37 million for the quarter.
• Following a previous earnings report in May where the company missed estimates, Quipt Home Medical saw its stock price reach $2.41, with market analysts reporting a mixed range of stock ratings.
• Institutional investors currently own 42.85% of Quipt's stock, and Jane Street Group recently acquired a new stake, indicating ongoing interest in the company's financial prospects.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) will likely be releasing its Q3 2025 earnings data after the market closes on Monday, August 11th. Analysts expect Quipt Home Medical to post earnings of $0.03 per share and revenue of $80.37 million for the quarter.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.09). The business had revenue of $57.40 million for the quarter, compared to the consensus estimate of $88.29 million. Quipt Home Medical had a negative net margin of 3.66% and a negative return on equity of 8.38%. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Quipt Home Medical Price Performance

Shares of QIPT traded up $0.10 during mid-day trading on Monday, reaching $2.41. The stock had a trading volume of 166,819 shares, compared to its average volume of 544,815. The firm has a market cap of $104.47 million, a price-to-earnings ratio of -11.45 and a beta of 0.59. Quipt Home Medical has a 12 month low of $1.35 and a 12 month high of $3.70. The business has a fifty day moving average of $1.96 and a 200 day moving average of $2.24. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.85 and a current ratio of 1.22.

Institutional Investors Weigh In On Quipt Home Medical

A hedge fund recently bought a new stake in Quipt Home Medical stock. Jane Street Group LLC bought a new stake in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 53,105 shares of the company's stock, valued at approximately $124,000. Jane Street Group LLC owned 0.12% of Quipt Home Medical at the end of the most recent quarter. Institutional investors own 42.85% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on QIPT shares. Wall Street Zen lowered shares of Quipt Home Medical from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Benchmark reiterated a "buy" rating and issued a $4.00 price target (down from $6.00) on shares of Quipt Home Medical in a research report on Wednesday, May 14th. Finally, Canaccord Genuity Group reiterated a "hold" rating and issued a $1.70 price target (down from $4.00) on shares of Quipt Home Medical in a research report on Tuesday, May 13th.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.